Loading…
HCA Healthcare, Inc. is projected to rise to $444.06 by 2027, a +9% move from its current price of $406.59. HCA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $400.43 | $406.72 | $413.11 | +0.03% |
| Jul 14 | $397.97 | $406.85 | $415.92 | +0.06% |
| Jul 15 | $396.13 | $406.98 | $418.12 | +0.10% |
| Jul 16 | $394.61 | $407.11 | $420.00 | +0.13% |
| Jul 17 | $393.28 | $407.24 | $421.69 | +0.16% |
| Jul 18 | $392.10 | $407.37 | $423.23 | +0.19% |
| Jul 19 | $391.02 | $407.49 | $424.66 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $391.02 | $407.49 | $424.66 | +0.22% |
| Week 2 | $385.25 | $408.40 | $432.94 | +0.45% |
| Week 3 | $381.08 | $409.31 | $439.63 | +0.67% |
| Week 4 | $377.73 | $410.22 | $445.51 | +0.89% |
| Week 5 | $374.90 | $411.13 | $450.87 | +1.12% |
| Week 6 | $372.44 | $412.05 | $455.87 | +1.34% |
| Week 7 | $370.26 | $412.97 | $460.60 | +1.57% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities.
Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Healthcare, Inc. trades at $423.11 per share and has a market cap of $93.86B. It is ranked 169.
Near-term technical picture shows bullish sentiment with RSI14 at 70, SMA50 at $401.54, and SMA200 at $459.97. Support is seen at $361.32 and resistance at $423.11.
The 30-day price range runs from $381.38 to $469.41, reflecting a constructive near-term trading band. Forecasts imply a continued upside path through 2026-2050, with the 2026 avg priced at $423.11 and a long-run trajectory toward higher levels, including a 2030 avg of $632.90 and a 2050 avg of $2,667.51, accompanied by rising ROIs.
A major floor 17.6% below — a decisive break under it would weaken the trend.
The nearest floor, 11.1% below — buyers have tended to step in here.
The nearest ceiling, 4.1% above — a clean break opens room to run.
A major ceiling 34.1% above — clearing it would confirm fresh momentum.
Key HCA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $413.28 | Sell | $408.82 | Sell |
| MA 10 | $404.40 | Buy | $404.72 | Buy |
| MA 20 | $394.93 | Buy | $399.11 | Buy |
| MA 50 | $399.86 | Buy | $408.75 | Sell |
| MA 100 | $451.31 | Sell | $429.55 | Sell |
| MA 200 | $460.05 | Sell | $435.63 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.00 | Neutral |
| Stoch RSI (14) | 54.23 | Neutral |
| CCI (20) | 71.12 | Neutral |
| Williams %R (14) | -35.82 | Info |
| MACD (12,26,9) | 3.63 | Buy |
| ROC (12) | 5.08 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 64.18 | Neutral |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | 25.70 | Buy |
| Ultimate (7,14,28) | 67.10 | Neutral |
| Momentum (10) | 19.65 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 414.80 | Sell |
| ADX (14) | 20.21 | Buy |
| ATR (14) | 5.83 | Info |
The 30-day technical picture is bullish overall.
RSI14 is 70, signaling strong momentum. The stock trades above the 50-day average of $401.54 but below the 200-day average of $459.97, indicating a near-term positive bias with a degree of long-term ownership in mind.
Key near-term levels: support at $361.32 and resistance at $423.11. The 30-day range spans from a low of $381.38 to a high of $469.41, outlining the immediate trading envelope.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $361.32 | $406.59 | $527.82 | 0% | Neutral | |
| $363.69 | $444.06 | $566.85 | +9% | Neutral | |
| $401.69 | $499.68 | $655.10 | +23% | Bullish | |
| $412.29 | $520.77 | $697.31 | +28% | Bullish | |
| $465.38 | $595.76 | $812.09 | +47% | Bullish | |
| $539.46 | $699.04 | $967.92 | +72% | Bullish | |
| $562.43 | $737.03 | $1,035.05 | +81% | Bullish | |
| $598.25 | $792.24 | $1,126.99 | +95% | Bullish | |
| $607.17 | $812.04 | $1,168.97 | +100% | Bullish | |
| $612.98 | $827.57 | $1,204.58 | +104% | Bullish | |
| $884.63 | $1,245.69 | $1,900.12 | +206% | Bullish | |
| $1,632.29 | $2,465.12 | $4,030.66 | +506% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $361.32 | $406.59 | $490.74 | +0.00% |
| August 2026 | $360.52 | $421.99 | $504.61 | +3.79% |
| September 2026 | $355.86 | $418.54 | $504.40 | -0.82% |
| October 2026 | $358.31 | $423.15 | $513.33 | +1.10% |
| November 2026 | $365.40 | $433.03 | $528.22 | +2.33% |
| December 2026 | $362.10 | $430.51 | $527.82 | -0.58% |
Click any year to see its month-by-month HCA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, HCA could reach as high as $527.82, with a base case around $406.59 and support toward $361.32 — roughly 0% from $406.59. A consolidation phase looks the most probable path here.
Expect HCA to range from $363.69 to $566.85 through 2027. The $444.06 average target implies a +9% move from current prices. That is up +9% on the projected 2026 average. Price action looks broadly range-bound.
The HCA price prediction for 2028 points to an average of $499.68 (low $401.69, high $655.10) — a potential gain of +23% on today's $406.59. Buyers look set to stay in control over this stretch.
In 2029, HCA is projected to trade between $412.29 and $697.31, averaging $520.77 — a potential gain of +28% from today's $406.59. That is up +4% on the projected 2028 average. Momentum favours further upside here.
HCA Healthcare, Inc.'s 2030 outlook centres on $595.76, within a $465.38 to $812.09 range. That is up +14% on the projected 2029 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, HCA could reach as high as $967.92, with a base case around $699.04 and support toward $539.46 — roughly +72% from $406.59. Momentum favours further upside here.
Expect HCA to range from $562.43 to $1,035.05 through 2032. The $737.03 average target implies a +81% move from current prices. That is up +5% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The HCA price prediction for 2033 points to an average of $792.24 (low $598.25, high $1,126.99) — a potential gain of +95% on today's $406.59. Momentum favours further upside here.
In 2034, HCA is projected to trade between $607.17 and $1,168.97, averaging $812.04 — a potential gain of +100% from today's $406.59. That is up +2% on the projected 2033 average. Buyers look set to stay in control over this stretch.
HCA Healthcare, Inc.'s 2035 outlook centres on $827.57, within a $612.98 to $1,204.58 range. That is up +2% on the projected 2034 average. That marks a +104% change versus current levels. Momentum favours further upside here.
By 2040, HCA could reach as high as $1,900.12, with a base case around $1,245.69 and support toward $884.63 — roughly +206% from $406.59. Buyers look set to stay in control over this stretch.
Expect HCA to range from $1,632.29 to $4,030.66 through 2050. The $2,465.12 average target implies a +506% move from current prices. That is up +98% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HCA today (≈ 2.45948 HCA) could be worth
$6,062.91
+$5,062.91 (+506%) by 2050 · US Dollar
Based on the average projected HCA price of $2,465.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCAwould be worth at today's price.
$1,000 invested in HCA on Jul 10, 2025 (≈ 2.643265 HCA) would be worth
$1,074.73
+$74.73 (+7.5%) today · 1.07× · US Dollar
Based on a HCA entry price of $378.32 vs. today's $406.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $410.5 | $990.48 | -1.0% |
| 1 month ago | $373.34 | $1,089.06 | +8.9% |
| 3 months ago | $495.47 | $820.61 | -17.9% |
| 6 months ago | $474.32 | $857.21 | -14.3% |
| 1 year ago | $378.32 | $1,074.73 | +7.5% |
| All time (5.0y) ago | $219.23 | $1,854.63 | +85.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCA forecast.
Our base-case forecast reaches $810.00 around 2034.
Implied market cap at $810.00: $179.69B
The multi-year forecast shows notable upside with advancing price levels and ROIs. For 2030, the avg price is $632.90, with a min of $494.31, a max of $862.86, and a projected ROI of 49.6% in a bullish environment.
Looking further to 2040, the avg price is $1,343.64, with a min of $954.11, a max of $2,049.72, and a projected ROI of 217.6% in a bullish environment.
By 2050, the avg price is $2,667.51, with a min of $1,766.18, a max of $4,361.87, and a projected ROI of 530.5% in a bullish environment.
These are estimates, not guarantees, and outcomes depend on market conditions and other factors. They illustrate a path of rising values and substantial upside potential over the long term.
Tap a question to reveal the answer.
The 2030 forecast shows min $494.31, avg $632.90, max $862.86 with a ROI of 49.6% and bullish sentiment.
Forecasts indicate bullish sentiment from 2028 onward, with 2030 avg $632.90 and ROI 49.6%, 2040 avg $1,343.64 with ROI 217.6%, and 2050 avg $2,667.51 with ROI 530.5%; these are estimates, not guarantees.
Yes, the 2032 forecast lists min $597.04, avg $782.48, max $1,099.05 and a bullish sentiment, indicating potential to exceed $1,000 in that year’s range.
Current price is $423.11 and market cap is $93.86B.
The 30-day range is from a low of $381.38 to a high of $469.41.
HCA Healthcare, Inc. Community Discussion
0Share your HCA Healthcare, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.